Purpose-built AI.

Every product in the DataFlow Agents portfolio is designed to solve a specific, high-value problem with state-of-the-art AI. We don't build generic tools. We build AI products that fit into your world and make it measurably better.

Now shipping
[ 01 / 03 ]

Our flagship product

// GEO / AI marketing intelligence

GeoFlow.

Search has changed forever. Hundreds of millions turn to ChatGPT, Claude, Gemini, Grok, and Perplexity for product and service recommendations. GeoFlow measures, scores, and grows your brand's presence across every major AI platform.

From the Labs
[ 02 / 03 ]

Two more in active development.

// Enterprise · Tech intelligence

Technology Dependency Mapping.

An AI-powered dependency mapping platform that automatically scans, visualizes, and analyzes the relationships within your technology ecosystem — giving engineering and leadership teams a live map of risk, redundancy, and opportunity.

Users
CTOs · DevOps
Connects
ITSM · CI/CD
// Healthcare · Revenue cycle

Medicare Billing Automation.

An AI-powered billing automation platform that intelligently processes Medicare claims, catches errors before submission, suggests correct coding, and automates follow-up on denied claims — all within a HIPAA-compliant environment.

Users
Hospital RCM
Codes
ICD-10 · CPT
Product philosophy
[ 03 / 03 ]

How every product earns its place.

Real problems, not hypotheticals.

Every product solves a specific, named business problem — not a model demo dressed up as a use case.

Built for scale from day one.

Designed to work for a 10-person team and a 10,000-person enterprise. Multi-tenancy and audit trails are not afterthoughts.

Security and compliance baked in.

HIPAA, SOC2, GDPR — built into architecture, not bolted on with policy documents.

Always evolving with the frontier.

Our products are supported by our team, informed by our Labs, and always evolving.

Have a problem worth building for?

If you operate at the intersection of a real business pain and the AI frontier, we'd love to hear about it. Lab partnerships, beta access, or just a conversation.